Triple-negative breast cancer (TNBC), also known as triple-negative breast cancer (TNBC), is named for the absence of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) (Yeo and Guan, 2017). This evidence concerns the gene ESR1 and triple-negative breast carcinoma.